Day: February 9, 2022

NEW YORK/Malmö, Feb. 08, 2022 (GLOBE NEWSWIRE) — byNordic Acquisition Corporation (the “Company”), today announced that it has priced its initial public offering of 15,000,000 units at $10.00 per unit.   The units will be listed on the NASDAQ Global Market (“Nasdaq”) and will begin trading tomorrow, Wednesday, February 9, 2022, under the ticker symbol “BYNOU.”  Each unit consists of one share of the Company’s Class A common stock and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share.  Only whole warrants are exercisable and will trade.  Once the securities comprising the units begin separate trading, shares of the Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “BYNO”...

Magnite now enables advertisers to buy Samsung TV Plus inventory programmatically NEW DELHI, India, Feb. 09, 2022 (GLOBE NEWSWIRE) — Magnite (Nasdaq: MGNI), the largest independent sell side advertising platform, announced today it has been selected by Samsung Ads to power programmatic OTT and CTV inventory for Samsung TV Plus in India. Samsung Ads is the media and advertising division of Samsung Electronics, a leading provider of advanced TV advertising inventory powered by the largest global source of TV data. Magnite is already the SSP of choice for Samsung Ads in the US, EMEA and LATAM. Samsung TV Plus, which launched in India in March 2021, offers an internet-based TV experience to consumers with instant access to a wide range of exciting and premium content across news, sports, music, movies, entertainment and more. Users...

HOUSTON, Feb. 08, 2022 (GLOBE NEWSWIRE) — Itafos Inc. (TSX-V: IFOS) (the “Company”) announced today the resumption of sulfuric acid production and sales at Arraias. The recommissioning of the previously idled sulfuric acid plant was completed on schedule, within budget and with no reportable environmental releases or recordable incidents. “We are pleased to have safely and successfully completed the recommissioning of the sulfuric acid plant at Arraias. While we continue to evaluate strategic alternatives for Arraias, we are opportunistically restarting the sulfuric acid plant to supply market demand and deliver positive margins,” said G. David Delaney, CEO of Itafos. Arraias’ sulfuric acid plant has production capacity of 220kt per year. The Company expects to operate the sulfuric acid plant at Arraias with a base load capacity...

FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the pricing of its previously announced underwritten public offering of 51,250,000 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, at a public offering price of $0.30 per unit. The warrants have an exercise price of $0.30 per share, are immediately exercisable and will expire five years from the date of issuance. Zosano has granted the underwriter a 30-day option to purchase up to an additional 7,687,500 shares of common stock and/or additional warrants to purchase up to 7,687,500 shares of common stock. Maxim Group LLC is acting as the sole book-running manager for the offering. The gross proceeds of the offering are expected...

Singapore, Feb. 08, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Society Pass Incorporated (Nasdaq: SOPA) (“SoPa” or the “Company”), a leading Southeast Asian data-driven loyalty platform, today announced the pricing of its underwritten public offering of 3,030,300 shares of common stock and accompanying warrants to purchase up to 3,030,300 shares of common stock.  Each share of common stock is being sold together with one warrant at a combined purchase price of US$3.30. The warrants will be immediately exercisable at a price of US$3.30 per share and will expire five years from the date of issuance. The shares of common stock and accompanying warrants can only be purchased together in the offering, but will be issued separately and will be immediately separable upon issuance. The warrants will not be listed on any exchange....

Vancouver, British Columbia, Feb. 08, 2022 (GLOBE NEWSWIRE) — Forty Pillars Mining Corp. (the “Company” or “Forty Pillars”) (CSE:PLLR) announces that pursuant to a directors resolution, the Company intends to consolidate its capital on a one-new-for-2-old basis. The name of the Company will not be changed and the trading symbol will remain the same. The Company’s 28,985,174 outstanding common shares will be consolidated into approximately 14,492,587 outstanding shares. The post-consolidated common shares will have a new CUSIP: 349801209 / ISIN CA3498012093. The share consolidation is expected to allow the Company to gain access to more attractive financings and assets as a result of a tighter capital structure and higher share price. The effective date of the share consolidation is subject to the Company’s filings with the Canadian...

HALIFAX, Nova Scotia, Feb. 08, 2022 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR) has received the CE mark for its REVEALCOVID-19® PLUS Total Antibody Test. The test will be available in Europe and any countries accepting the CE mark. MedMira offers its tests in a single pack for individual use and bulk packaging for standard screening. REVEALCOVID-19® PLUS detects the presence of total antibodies against SARS-CoV-2 generated by either a previous infection or post vaccination. The continuous screening for antibodies is essential to keep track of a person’s current antibody status to either determine the effectiveness of post vaccination or a person’s status post-infection. Based on the published data made available this month, the total antibody level including the neutralizing antibodies of individuals who...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) — Golden Tag Resources Ltd. (“Golden Tag” or the “Company“) (TSX.V: GOG) (OTCQB: GTAGF) is pleased to announce the closing of the first tranche (the “First Tranche“) of the non-brokered private placement announced on January 20, 2022 (the “Offering”). Under the First Tranche, the Company issued 7,166,670 Units, for aggregate gross proceeds of $1,791,667.50. The Offering Each Unit consists of one common share (“Common Share”) and one-half of one common share purchase warrant (each, a “Warrant”). Each whole Warrant issued pursuant to the First Tranche entitles the holder thereof to acquire one Common Share at a price of C$0.40 until February 8, 2024. The Warrants contain an acceleration...

TORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has arranged a shares for debt transaction to settle an aggregate of $424,767.07 in interest accrued up to December 31, 2021 on all five of the deferred convertible notes outstanding and disclosed in the Company’s financial statements (the “Notes”). The shares for debt settlement is pending final approval from the TSX Venture Exchange (TSXV) which will be followed by the Company issuing 117,990 common shares (Settlement Shares) at a deemed price of $3.60 to the holder of the Notes and who is an arms-length party to the Company. The terms of the Notes originally required the issuance of common shares to settle interest owing by the Company and subject to TSXV approval pursuant...